CClinicalTrials.gg
CompletedNCT07546968Updated Apr 23, 2026

CiNPWT Using in Mastectomy Wound Care After DIEP Flaps for Breast Reconstruction

An observational study in Mastectomy, Breast Reconstruction and Closed-Incision Negative Pressure Therapy, sponsored by Chiayi Christian Hospital. Completed at 1 site in Taiwan. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-23.

Sponsored by Chiayi Christian Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
253
Ages
18 Years and older
Sex
Female
01

Study summary

Background: Closed-incision negative pressure wound therapy (ciNPWT) is effective in reducing postoperative complications, yet its use in free flap breast reconstruction mastectomy wound remains controversial due to concerns that external pressure may compromise the microvascular pedicle.

Methods: A retrospective comparative study was conducted on 253 patients (283 flaps) undergoing immediate DIEP flap reconstruction between 2012 and 2025. Patients were stratified into a ciNPWT group and a conventional dressing group. Outcomes included flap survival, wound complications, healing time, and length of stay (LOS). Multivariable regression models adjusted for confounders, including BMI and neoadjuvant chemotherapy.

02

Conditions studied

  • Mastectomy
  • Breast Reconstruction
  • Closed-Incision Negative Pressure Therapy

Keywords

  • ciNPWT
  • Wound healing
  • DIEP flap
  • Microvascular safety
03

In context

Lead sponsor

Chiayi Christian Hospital is the lead sponsor of 26 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

A retrospective comparative study was conducted on 253 patients (283 flaps) undergoing immediate DIEP flap reconstruction between 2012 and 2025.

Inclusion criteria

- A retrospective comparative study was conducted on 253 patients (283 flaps) undergoing immediate DIEP flap reconstruction between 2012 and 2025.

Exclusion criteria

Exclusion Criteria:

  • Age \<18
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
253 participants (actual)
Patient registry
No

Groups and cohorts

  • CiNPWT Cohort

    This retrospective cohort includes patients who underwent mastectomy followed by immediate breast reconstruction with deep inferior epigastric perforator (DIEP) flap and received closed-incision negative pressure wound therapy (CiNPWT) applied to the mastectomy incision and/or abdominal donor site as part of postoperative wound management.

    Device: Closed-Incision Negative Pressure Wound Therapy (CiNPWT)

  • Conventional Wound Dressing

    This retrospective cohort includes patients who underwent mastectomy followed by immediate breast reconstruction with DIEP flap and received conventional postoperative wound dressing according to institutional standard wound care protocol.

Interventions

  • DeviceClosed-Incision Negative Pressure Wound Therapy (CiNPWT)

    Application of a negative pressure wound therapy system over primarily closed surgical incisions to reduce surgical site complications, including infection, seroma formation, wound dehiscence, and delayed wound healing.

06

What researchers measure

Primary outcomes

  1. Incidence of surgical site complications

    Flap survival rate(%), wound complications rate(%), healing time (minute), and length of stay (LOS)(days). Multivariable regression models adjusted for confounders, including BMI 【Body Mass Index ,body weight(kg)/height(m)/height(m)】and neoadjuvant chemotherapy.

    Time frame: Within 30 days following surgery

07

Study locations

1 site
  • Ditmanson Medical Foundation Chiayi Christian Hospital
    Chiayi City, 60002, Taiwan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07546968
Lead sponsor
Chiayi Christian Hospital
Responsible party
Sponsor
First posted
Apr 23, 2026
Start date
Sep 6, 2012
Primary completion
Dec 31, 2025
Completion
Dec 31, 2025
Last update
Apr 23, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion